Smoking habit changes and body weight: causal estimates from the British Household Panel Survey by Pieroni, Luca & Salmasi, Luca
Munich Personal RePEc Archive
Smoking habit changes and body weight:
causal estimates from the British
Household Panel Survey
Pieroni, Luca and Salmasi, Luca
10 December 2012
Online at https://mpra.ub.uni-muenchen.de/43465/
MPRA Paper No. 43465, posted 28 Dec 2012 12:24 UTC
Smoking habit changes and body weight:
causal estimates from the British Household Panel Survey
Pieroni L.*, Salmasi L.**
*University of Perugia (Italy) and University of the West of England (UK)
**University of Perugia (Italy)
Corresponding author: Pieroni L., Department of Economics, Finance and Statistics,
Via Pascoli 20, 06123 Perugia, Italy. E-mail: lpieroni@unipg.it
Abstract
This paper evaluates the causal relationship between smoking and body weight through two waves
(2004-2006) of the British Household Panel Survey. We model the effect of changes in smoking habits,
such as quitting or reducing, and account for the heterogeneous responses of individuals located at
different points of the body mass distribution by quantile regression. We investigate the robustness
of our results by means of a large set of control groups and the application of an instrumental vari-
able (IV) estimator. Our results reveal the positive effect of quitting smoking on weight changes,
which is also found to increase in the highest quantiles, whereas the decision to reduce smoking does
not affect body weight. Lastly, cost-benefit analysis reveals that quitting smoking implies savings
for the National Health Service which are much larger than the costs associated with increased obesity.
Keywords: Body Mass Index, Overweight and Obesity, QTE, Instrumental Variable Quantile
regression
JEL classification : I10, I12, I18
1 Introduction
Obesity is one of the major risks that individuals face during their life course, particularly
in the United States, but it also shows growing importance in Europe. As widely sug-
gested, this epidemic problem may be alleviated by changing some habits at individual
level, for example, by decreasing food consumption or promoting physical activity, but
other determinants, like smoking, may seriously influence individual results in terms of
weight. In fact, the decline in smoking rates, observed in the last few decades, was found
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to be associated with higher obesity rates (Chou et al. 2004, Rashad et al. 2006, Flegal
2007, Baum 2009, Liu et al. 2010), although existing empirical studies did not reach a
consensus. Gruber & Frakes (2006) reported the opposite of the expected relationship,
whereas Nonnemaker et al. (2009) found no significant evidence. This ambiguity arises
because changes in smoking habits and weight may also be affected by endogeneity bias
deriving from unobserved confounders (Baum 2009), or reverse causality (Cawley et al.
2004), implying that a careful identification strategy must be used to estimate these effects
causally.
To estimate the extent to which changes in smoking habits modify individual body
weight, expressed in terms of body mass index (BMI), we used a longitudinal dataset
extracted from two waves (2004-2006) of the British Household Panel Survey (BHPS),
which includes information on smoking and a large number of socio-demographic variables.
We exploited the fact that we observed a random sample of the population of smokers
in two periods, in which some subjects experienced the transition from smoking to non-
smoking, while others reduced their cigarette consumption. The longitudinal framework of
the dataset allowed us to separate the effect of quitting or substantially reducing cigarette
consumption controlling for unobservable individual time-invariant characteristics.
Our analysis differs from those in the current literature in three important respects.
First, we propose a general framework based on a multi-treatment model to test whether a
substantial reduction in cigarette consumption can contribute to affecting weight changes.
We chose to analyse reductions in smoking because we noted from descriptive analysis
that part of the weight variation in obese people was associated with reduced cigarette
consumption, rather than only with quitting smoking. Second, we focus on the effects
of smoking on different quantiles of BMI distribution. That is, we extend the quantile
regression within a difference-in-differences (DID) framework, to measure the quantile
treatment effect (QTE). This allows us to evaluate the proposed model across the condi-
tional BMI distribution, taking into account the influence of unobservable characteristics.
Third, we evaluate possible heterogeneous effects of quitting or reducing smoking for in-
dividuals belonging to different BMI clinical classes, specifying an extension of our model
which includes a full set of interactions between treatment and BMI classes. In this way,
we estimate the effect of changes in smoking habits on BMI for overweight and obese
individuals, which are particularly of interest for policy-makers, and use the estimated
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parameters to compare social costs from increased obesity with benefits from quitting
smoking.
We propose a strategy which estimates the effects on weight of changes in smoking
habits by selecting various ‘’control groups” in addition to the natural control group of
‘’smokers”, in which each group is able to consider specific confounders. We also propose
a sensitivity analysis to investigate to what extent the estimates derived from different
identifications are distant from one another.
Our empirical results are the following. First, we document a significant increase in
body weight for quitters, particularly if obese. Although point estimates are not very
large in magnitude, they increase across BMI distribution. Second, robustness analysis
generally confirms these findings when various control groups are used and when an IV
estimator is implemented. Third, even though the obese and overweight groups tend to
increase less or even decrease BMI in the period considered, they show larger effects from
quitting smoking on weight, with respect to normal-weight people. Fourth, results from
a social cost-benefit analysis indicate that quitting smoking implies much larger savings
in health costs than the costs associated with increased obesity.
In Section 2, we summarise the main features of our empirical framework. We extend
the discussion of our strategy from the average treatment effect (ATE) to the quantile
treatment effect (QTE), to measure the relationships tested on the conditional BMI dis-
tribution. A multi-treatment model of the effect of cigarette reduction on weight changes
is proposed, in which quitting is a special case (e.g., single treatment model). In Section 3,
we describe our data and focus particularly on DID identification, using a large number
of control groups. Section 4 lists our main results and discusses the robustness of the
analyses. The policy implications of the cost-benefit calculation are discussed in Section
5, and Section 6 concludes.
2 Modelling the causal effects of smoking on weight changes
2.1 Preliminaries
Our aim was to estimate the causal effect of changes in smoking habits on BMI in a
representative sample of the UK population. Let us consider a benchmark model, in
which BMI(i, t) is the body mass index of individual i at time t and in which, in a
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hypothetical period, some fraction of the population reduces its cigarette consumption
(e.g., non-random treatment). That is, individuals are observed in pre-treatment period
t = 0 and in post-treatment period t = 1, in which D(i, t) = 1 if an individual has been
exposed to the treatment between t = 0 and t = 1, and D(i, t) = 0 if not (control group).
From a theoretical point of view, we assume that ‘’treated” subjects in t = 1 decide to
reduce their smoking up to the extreme case of ‘’zero cigarettes smoked” (i.e., quitting), a
situation which is of great interest in the health economics literature, because it is linked
with addiction issues (Becker & Murphy 1988, Baltagi & Griffin 2001).
As in Ashenfelter & Card (1985), we assume that the outcome of interest (i.e. BMI)
is generated through a component of variance process. A sufficient condition to identify
the effect of smoking status changes is that selection for treatment, conditional on covari-
ates, does not depend on individual transitory shocks; that is, P (D(i, 1) = 1|ǫ(i, t)) =
P (D(i, 1) = 1) for t = 0, 1 (Abadie 2005). The model is formally written as:
BMI(i, t) = µ+X(i)
′
π(t) +D(i, 1)η + δt+ βD(i, t) + ǫ(i, t) (1)
where δ is a time-specific component, β is the effect of treatment, η represents unobserved
individual specific characteristics such as various concerns about health, and X(i) is the
vector of observed individual characteristics which is assumed to be uncorrelated with
individual-transitory shocks ǫ(i, t), with mean zero at each period and possibly correlated
in time.
Provided that D is not endogenous, the empirical specification of equation (1) is given
as:
E[BMI|D, t,X] = µ+X(i)
′
π(t) +D(i)η + tδ + (D(i)× t)β (2)
in which the OLS estimate of β is the counterpart of the conditional ATE, within the DID
approach. In fact, the ATE can be expressed as the difference between the conditional
means of treatment and control groups in the two observed periods:
E[BMI|D = 1, t = 1, X]− E[BMI|D = 1, t = 0, X]−
E[BMI|D = 0, t = 1, X]− E[BMI|D = 0, t = 0, X] = β.
(3)
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Here we assume that the effect of changes in smoking status may vary according to
individual unobserved characteristics, like for example attitude toward risk. The previous
model is consequently extended to take into consideration this aspect and a quantile re-
gression estimator is used to obtain the QTE, that is more appropriate than the usual ATE
since is able to control for quantile unobserved heterogeneity (Doksum 1974). Formally,
the quantile regression model applied to our case is expressed as:
q[BMI|D, t,X, θ] = µθ +X(i)
′
πθ(t) +D(i,t)ηθ + tδθ + (D(i)× t)βθ (4)
where the model parameters are obtained by minimising the weighted sum of residuals1.
Thus, q[BMI|D, t,X, θ] is the estimated BMI at the θ − th conditional quantile and θ is
chosen in the interval (0, 1). δθ, ηθ, πθ and βθ are parameters, which now also depend on
θ, associated with the already described effects of time, unobservable characteristics, co-
variates, and the treatment effect. Under the same identifying assumptions used for ATE,
the quantile regression estimates of (βθ) in (4) are the DID estimates of the conditional
QTE.
2.2 The model
Here, first, we extend the model proposed in the previous section to estimate ATEs and
QTEs in a multiple treatment framework. We justify this extension because we want to
test whether reducing smoking may also be responsible for weight increases: that is, if
smoking reductions are relevant in explaining weight changes, then estimates of the effect
of quitting will be biased when individuals who are reducing the number of cigarettes
they smoke are also included in control groups.
With respect to quitting, reducing smoking is expected to have a smaller influence in
this case, at least because addictive effects are weaker. The empirical evidence shows that
many individuals try to quit smoking by gradually reducing the number of cigarettes they
smoke each day. This method usually produces minimal or no withdrawal symptoms when
the reduction is small, but may cause significant ones when the cut is greater or more
sudden. For this reason equation (5) includes the potential effects of reducing smoking,
specifying the following multi-treatment model:
1See, Koenker & Bassett (1978) and Koenker & Hallock (2001) for a discussion of quantile regression model.
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BMI(i, t) = µ+X(i)
′
π(t) +
n∑
j=1
Dj(i, t)ηj + δt+
n∑
j=1
(Dj(i, t)× t)βj + ǫ(i, t) (5)
where D(j) indicates the j−th treatment group, with j = 1, ...n, and the other parameters
and variables are those already described. We simplify the model by restricting the
possible cases (treatments) to two: i) individuals who quit smoking, i.e., 100% reduction
of cigarette consumption, the extreme case; ii) individuals who do not quit smoking but
who significantly reduce their cigarette consumption, by at least 50%.
The ATEs for extended model (5) are calculated as the difference between the condi-
tional means of the treatment and control groups in the two observed periods. Formally,
the time difference of the conditional means of the treatment group is given as:
E[BMI|D = 1, t = 1, X]− E[BMI|D = 1, t = 0, X]
= (µ+X(i)
′
π +
n∑
j=1
βj +
n∑
j=1
ηj + δ)− (µ+X(i)
′
π +
n∑
j=1
ηj) =
n∑
j=1
βj + δ,
(6)
while that of the control group is:
E[BMI|D = 0, t = 1, X]− E[BMI|D = 0, t = 0, X]
= (µ+X(i)
′
π + δ)− (µ+X(i)
′
π) = δ.
(7)
The result of the double difference is
∑n
j=1 βj, which represents the conditional ATEs
to be estimated.
Analogously, we can estimate the multi-treatment model using a quantile regression
framework:
BMIθ(i, t) = µθ +X(i)
′
πθ(t) +
n∑
j=1
Dj(i, 1)η
θ
j + δ
θt+
n∑
j=1
(Dj(i, t)× t)β
θ
j + ǫ
θ(i, t). (8)
Based on the same identifying condition, the QTE estimator is consistently identified
through DID as:
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βθ∗ =
n∑
j=1
βθj . (9)
It is worth noting that overweight and obese individuals are of great interest to policy-
makers, because preventing weigth excess produces both significant gains in terms of
health and reductions in terms of costs for treating their related illnesses. Thus, we con-
sider possible heterogeneous treatment effects, across BMI clinical thresholds, by speci-
fying the following model for the usual four BMI classes allowing for multiple treatment
effects:
BMI(i,t,h) = µ+X(i)
′
π(t) +
4∑
h=1
2∑
j=1
Dj(i,h)ηj,h +
4∑
h=1
tδh
+
4∑
h=1
2∑
j=1
(Dj(i,h)× t)βj,h + ǫ(i, h),
(10)
where subscript h ranges from 1, which represents the BMI threshold corresponding to
underweight individuals (i.e., BMI < 19), to 4, which refers to the obese category (i.e.,
BMI ≥ 30)2. The OLS estimate of βj,h is still the DID estimate of the ATE of treatment
j for group h.
The model which only includes quitting smoking as treatment can be derived as a
nested specification of (10) under the assumption that smoking reductions do not affect
body weight significantly (i.e. j = 1):
BMI(i,h) = µ+X(i)
′
π +
4∑
h=1
D(i,h)ηh +
4∑
h=1
tδh
+
4∑
h=1
(D(i,h)× t)βh + ǫ(i, h).
(11)
2Normal-weight and overweight range from 19− 24.99 and 25− 29.99 of BMI, respectively.
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3 Source, identification strategy and descriptive analysis
3.1 Source
The dataset used in this paper was extracted from the BHPS, a multi-purpose survey
which reports information at both individual and household level for a representative
panel of the UK population. The original sample was drawn from 250 areas of England,
and was subsequently enlarged to include Scotland and Wales in 1999 and Northern
Ireland in 2002. The dataset is composed of 18 waves and the first survey was conducted
in 1980: for our purposes, we use the 14th and 16th waves, conducted respectively in
2004 and 2006, because they also recorded two anthropometric characteristics, height and
weight, which allow us to calculate BMI (weight/height2) for a balanced panel of 13,230
individuals.
3.2 Identification
One difficulty in evaluating the effectiveness of policies aimed at reducing smoking is to
verify whether such interventions also have unintended consequences on body weight.
Estimating causal parameters is made difficult because the relationship between smoking
and BMI is affected by endogeneity due to unobservable characteristics or reverse causality.
To cover these issues, part of the literature uses the introduction of smoking bans as
an instrument for smoking, within an IV framework (Liu et al. 2010, Pieroni & Salmasi
2012). Although such anti-smoking policies are expected to affect negatively smoking
habits, they are certainly not correlated with the unobserved characteristics affecting
body weight.
Another approach proposed in the literature uses a difference-in-differences (DID)
strategy with panel data. For example, Baum (2009) used the DID estimator to identify
the above relationship accounting for individual unobservable time-invariant characteris-
tics affecting cigarette consumption and weight differently for both treatment and control
groups. In the present work, in view of the panel nature of our dataset, we also adopt the
DID approach and solve endogeneity issues by defining different control groups, aimed at
controlling for the bias induced by reverse causality or unobservable characteristics.
In line with the models presented in Section 2, we start our discussion on model
identification by defining the following treatment and control groups:
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D1. Treated group of smokers who quit smoking (TGQ): individuals who were
smokers in 2004 and became non-smokers in 2006.
D2. Treated group of smokers who reduced smoking (TGR): individuals who
were smokers in 2004 and significantly reduced cigarette consumption (by at least 50%)
in 2006.
D3. Control group of smokers (CGS): individuals who were smokers in 2004 and
remained so in 2006.
Our evaluation strategy assumes that weight variations between 2004 and 2006 for
TGQ individuals are affected by quitting smoking and by a spontaneous dynamic (i.e.,
time-specific component), whereas individuals who continue to smoke (CGS) are only af-
fected by the spontaneous dynamic. We also evaluate the effect on a treatment group of
individuals who significantly3 reduced their cigarette consumption (TGR), because these
subjects are assumed to be qualitatively exposed to the same symptoms of metabolic
rate reduction, withdrawal and changes in eating habits which are responsible for increas-
ing weight, as shown in quitters by Dill et al. (1934), Jacobs et al. (1965), Glauser et al.
(1970) and Jacobs & Gottenberg (1981).
However, according to Cawley et al. (2004), smoking habits are influenced by body
weight if smokers do not quit because they are afraid of putting on weight. In this case,
estimates of the relationship between smoking and body weight are biased by reverse
causality. Then, comparing TGQ or TGR with CGS may produce biased estimates because
the estimated weight variation for the control group of smokers, CGS, is biased downwards
and consequently the estimated ATEs and QTEs are biased upwards.
We evaluate the magnitude of this effect by defining two control groups. The first
also includes non-smokers in the smokers’ control group4, CGALL, whereas the second
includes only non-smokers CGNS. Both groups are composed of individuals who keep
their cigarette consumption stable and who, in principle, are not affected by reverse
causality, like the CGS, because their weight does not affect their smoking decisions. We
formally define:
3We considered as significant a reduction of 50% of current cigarette consumption. We also carried out estimates with
thresholds of 30% and 70% for cigarette consumption reductions; the results were very similar to those obtained with the
50% threshold. All tables related to these estimates are available from the authors upon request.
4We excluded from this control group non-smokers who started smoking in 2006, irrespective of whether they were or
were not ex-smokers in 2004. We anticipate that the dimension within our sample (2.04%) is negligible for our estimates.
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D4. Control group of smokers and non-smokers (CGALL): individuals who were
smokers or non-smokers in 2004 and remained so in 2006.
D5. Control group of non-smokers(CGNS): individuals who were non-smokers in
2004 and remained so in 2006.
Since treatment is not randomly assigned in our dataset, treated and control groups
may also differ according to time-varying unobserved factors related to smoking and weight
decisions. In this case, the presence of unobserved heterogeneity may cause our baseline
estimates, comparing treatment groups (i.e., TGQ or TGR) with CGS, to be biased down-
wards. In fact, quitters are generally more concerned about their health and more oriented
towards the future, as discussed by McCaul et al. (2006) and their decision to quit smok-
ing may thus be seen as part of a more general attitude aimed at improving health -
for example, by also reducing weight in obese people. The presence of these individuals
in TGQ or TGR may bias the estimated weight variation as well as the estimated ATEs
downwards.
In order to take into consideration this aspect, we made up a new control group com-
posed of individuals who were smokers in 2004 and 2006, but who quit in 2008. That is,
the BMI variation of ‘’next period” quitters was considered as the most appropriate con-
trol group for the BMI variation of TGQ, because they have the most similar unobservable
characteristics according to future health behaviour. A similar strategy was proposed and
applied to the job market by Del Bono & Vuri (2011). Formally, our new control group
is defined as:
D6. Control group of ‘’next period” quitters (CGQ08): individuals who were
smokers in 2004 and 2006, but who quit in 2008.
Analogously we used the same argument as above to define a control group of individ-
uals who reduced smoking in 2008, defined formally as:
D7. Control group of ‘’next period” reducers (CGR08): individuals who were
smokers in 2004 and 2006, but who substantially reduced smoking in 2008.
In the next sub-section, we empirically justify the use of both the QTE estimator,
and the ATE to estimate the effects on weight changes of quitting or reducing cigarette
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consumption.
3.3 Preliminary analyses and covariates
To emphasize the differences between treated and control groups at different quantiles of
the outcome variable, we compared the estimated densities of BMI empirical distributions,
shown in Figure 1, of ‘’non-smokers” (solid line) and ‘’heavy smokers”5 (dashed line). The
estimated empirical distributions are both skewed and non-normally distributed and also
have different shapes. The empirical distribution of non-smokers is shifted to the right
with respect to that of heavy smokers, implying that the former group also has higher
BMI. This result is consistent with the hypothesis that changes in cigarette consumption
(reducing or quitting smoking) may increase overweight and obesity rates.
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Figure 1: BMI kernel density estimate, by smoking status
Table 1 (panel a) shows an average BMI increase of 0.85 points for TGQ and a smaller
variation for CGS (0.24 BMI points); the unconditional ATE, according to these two
groups, is therefore estimated to be 0.61 BMI points. Also according to other control
groups, the estimated ATE is about 0.6 BMI points, except for CGQ08, where it is slightly
larger. Panel (b) lists the effects of reducing smoking (TGR) on BMI; we estimate an
5We consider adults who currently smoke more than 20 cigarettes per day as ”heavy smokers”.
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ATE very close to zero (0.01) for this group. The same result holds for all control groups.
We had previously checked that BMI differences between smokers and non-smokers
were different over the empirical distribution. We then used the usual BMI clinical
thresholds to calculate unconditional ATEs for underweight, normal-weight, overweight
and obese individuals. Table 2 shows two important results. First, the effect of quitting
smoking on BMI is greater for obese individuals (range: 0.97 to 1.08 points), irrespec-
tive of control group used. Second, when we examine the effect of reducing cigarette
consumption, we find a negative, although small, effect on obese people (range: −.21 to
−.26 points), compensated by a (small) positive effect on normal-weight individuals. At
this stage, however, we cannot comment on the significance of these effects and leave the
discussion to the next sections.
Table 1: BMI absolute variations and ATEs (2004-2006), by smoking status group
N. obs BMI BMI Absolute variation ATE
Panel a 2004 2006 2004/2006 2004/2006
TGQ 443 25.04 25.89 0.85 -
CGS 2455 25.12 25.36 0.24 0.61
CGALL 10946 25.82 26.06 0.25 0.6
CGNS 8491 26.02 26.27 0.25 0.6
CGQ08 335 24.6 24.78 0.18 0.67
Panel b
TGR 694 25.02 25.3 0.28 -
CGS 1761 25.14 25.42 0.28 0
CGALL 10252 25.82 26.09 0.27 0.01
CGNS 8491 26 26.25 0.25 0.03
CGQ08 1011 25.46 25.69 0.23 0.05
Notes: TGQ and TGR: treated groups of quitters and individuals reducing consumption of cigarettes by more than 50%,
respectively. CGS, CGALL, CGNS and CG08: control groups (see subsection 3.2.)
We also include a full set of covariates, both time invariant and time varying, in
our model to control for observable individual characteristics. All time-varying variables
are introduced into the models as variations between waves, as in French et al. (2010).
The matrix X of covariates is composed of: gender; health status (five modalities, from
excellent to very poor); health status variations (positive variations, from very poor or
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Table 2: BMI absolute variations and ATEs (2004-2006), by smoking status group and BMI class
Absolute variation ATE
BMI classes < 19 19− 25 25− 30 > 30 < 19 19− 25 25− 30 > 30
TGQ 1.15 0.71 1 0.78 - - -
CGS 0.35 0.41 0.2 -0.3 0.81 0.3 0.8 1.08
CGALL 0.4 0.42 0.23 -0.21 0.75 0.29 0.76 0.99
CGNS 0.44 0.42 0.24 -0.19 0.72 0.29 0.76 0.97
CGQ08 0.41 0.36 -0.01 -0.19 0.74 0.35 1.01 0.97
TGR 0.51 0.41 0.28 -0.4 - - -
CGS 0.34 0.46 0.15 -0.43 0.16 0.25 0.13 0.03
CGALL 0.43 0.44 0.25 -0.18 0.08 0.28 0.03 -0.21
CGNS 0.46 0.43 0.27 -0.13 0.05 0.28 0.01 -0.26
CGQ08 0.29 0.4 0.19 -0.15 0.22 0.31 0.09 -0.25
Notes: TGQ and TGR: treated groups of quitters and individuals reducing consumption of cigarettes by more than 50%.
CGS, CGALL, CGNS and CG08: control groups (see, subsection 3.2). BMI clinical classes: < 19, underweight; 19− 25,
normal-weight; 25− 30, overweight; > 30, obese.
poor to good or excellent; and negative variations, the opposite); physical activity (at
least once a week or less); physical activity variations (positive and negative, from at
least once a week to less or the opposite); length of sickness (long-term versus short-term
or healthy); length of sickness variations (from long-term to short-term or healthy, or
the opposite); work conditions (weekly hours of work; strenuousness of job; presence
in the household of a working mother); variations in working conditions (changes in
number of weekly hours of work or job strenuousness); ethnic group membership (white
or other ethnicity); age (five classes, 18-29, 30-39, 40-49, 50-59, ≥ 60); net income (five
classes, by quintile of net income distribution); marital status (married; couple; divorced;
separated; widowed); marital status variations (from married, couple, divorced, separated,
widowed, to another category); education (degree; diploma; GCE A-level and/or O-level
examinations)6; and three country dummies (England, Wales, Scotland). We also include
a measure of alcohol consumption (five modalities of frequency with which the respondent
drinks outside the home, from ‘’at least once a week” to ‘’never”) which is considered as
a proxy for unobserved individual heterogeneity in addictive behaviour, since alcohol is
known to be a complement to smoking, at least in the Italian case (Aristei & Pieroni
6A-levels and O-levels refer to the examinations for the General Certificate of Education offered by educational in-
stitutions in the United Kingdom and a few of the former British colonies. In particular, A-levels were the subsequent
examinations for those who studied for a further two years after O-levels at the age of 16.
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2010). Time varying covariates are used in our specification to control for the effect of
various life-style shocks, mostly health-related, which could also have an effect on the
decision to quit smoking and may influence weight as well. In addition we included
a set of dummy variables recording whether subjects were underweight, normal-weight,
overweight or obese in 2004, and a full set of interactions with the time trend to account
for the different BMI dynamics observed in Table 2. These covariates are included as
proxies of health concerns or orientation towards the future of individuals with different
initial conditions in terms of BMI. Summary statistics of covariates for the treated (TGQ)
and smoker control groups (CGS) are listed in Appendix A.
4 Results
4.1 OLS estimates
In this section, we discuss the OLS estimates of the effect of quitting (e.g., single treatment
using TGQ) and both quitting or reducing (e.g., multi-treatment using TGQ and TGR)
on weight changes, with smokers (CGS) as the control group. Table 3 lists the estimated
coefficients. The parameters of the model with single treatment (first column of the upper
part of Table 3 are in line with the unconditional ATEs shown in Table 2; quitting smoking
leads to a small but significant increase in terms of BMI of about 0.59 (s.e.=0.100).
Moreover, there are not significant differences in terms of BMI between treated and control
groups, since η1 is not statistically different from zero. This result is not surprising
because, under this specification, we are comparing groups of individuals, who in 2004
were smokers and had similar initial conditions in terms of BMI. Instead, spontaneous
dynamic δ is positive and significant.
When we compare these results with those obtained with the other control groups,
CGNS and CGALL (Table 3), we find that the effect of quitting is slightly smaller than that
obtained from previous estimates, and is respectively 0.53 (s.e. = 0.095) and 0.54 (s.e. =
0.094). As expected the effect of quitting smoking on BMI estimated from these control
groups, which account for the effect of reverse causality, is lower than that estimated
through CGS. However, we can show that these differences are negligible in terms of
weight if we consider that the weight increase for an individual at the sample average -
with height of 1.70 m - who decides to quit smoking is 1.7 kg under CGS, whereas if we
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consider CGNS or CGALL the estimated weight increases are respectively 1.5 kg and 1.6
kg.
Also with CGNS or CGALL control groups BMI has a positive and significant trend.
The only difference with CGS worth mentioning regard the η1 coefficients, which now
are negative and significant. This result is in line with findings from the medical liter-
ature, according to Grunberg (1985), Klesges et al. (1989) and French & Jeffery (1995),
who found that smokers weighed less than non-smokers because smoking increases the
metabolic rate and thus the number of calories consumed by the body during the day:
after one cigarette is smoked, the heart may beat 10-20 times more than its normal rate
per minute, (Dill et al. 1934, Hiestand et al. 1940, Glauser et al. 1970), and the amount
of weight gained after quitting is usually close to the initial gap between smokers and
non-smokers, at least in the short term (Keys et al. 1966, Karvonen et al. 1959, Higgins
1967).
Table 3 also shows the estimated coefficients obtained with CG08 as the control group.
As expected, ”next period” quitters have equivalent initial conditions to those of current
smokers, as the non-significant η parameter shows. However, the ATE estimates (β1),
with this control group, are higher than the previous specifications and reach 0.63 (s.e.
= 0.142). In line with our expectation, this control group seems to be able to correct the
downward bias induced by unobservable variables, although the difference with respect
to our baseline estimates is quite limited, especially when considered in terms of weight.
In this case the estimated weight variation for a representative individual at the sample
mean is of 1.8 kg and is, as well as for the previous control groups, close to the weight
variation estimated with CGS.
The lower part of Table 3 lists parameters associated with the effects of both quitting
and reducing smoking (i.e., equation (5)). The estimated β1 and δ are close to those of
the upper part of the table, whereas the coefficient linked with smoking reduction, β2, is
non-significant.
4.2 Quantile estimates
In this section we examine the possibility that the effect of quitting smoking varies across
the conditional BMI distribution using the quantile regression model. Figure 2 shows the
scatter plot of unconditional versus conditional BMI distribution values, obtained from
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Table 3: Causal effect of cigarette consumption changes on BMI (2004-2006) by control group
a Treatment: quitting smoking
Variables CGS CGNS CGALL CG08
η1 -0.21 -0.29*** -0.25*** 0.03
(0.181) (0.077) (0.075) (0.105)
β1 0.59*** 0.53*** 0.54*** 0.63***
(0.100) (0.095) (0.094) (0.142)
δ 0.31*** 0.35*** 0.36*** 0.35**
(0.064) (0.033) (0.030) (0.158)
Constant 22.26*** 22.70*** 22.52*** 22.16***
(0.228) (0.177) (0.142) (0.590)
Observations 5,796 17,868 22,778 1,656
R-squared 0.80 0.80 0.80 0.78
Adj. R-squared 0.80 0.80 0.80 0.77
b Multi-treatment: quitting or reducing smoking
η1 -0.17 -0.29*** -0.25*** -0.15
(0.184) (0.077) (0.075) (0.192)
η2 0.10 -0.08 -0.02 0.12
(0.069) (0.062) (0.061) (0.079)
β1 0.61*** 0.53*** 0.54*** 0.63***
(0.103) (0.095) (0.094) (0.111)
β2 0.05 -0.03 -0.01 0.07
(0.078) (0.069) (0.068) (0.088)
δ 0.30*** 0.36*** 0.36*** 0.30***
(0.067) (0.032) (0.030) (0.088)
Constant 22.22*** 22.70*** 22.52*** 22.23***
(0.228) (0.162) (0.143) (0.283)
Observations 5,796 19,270 22,778 4,206
R-squared 0.80 0.80 0.80 0.80
Adj. R-squared 0.80 0.80 0.80 0.80
Notes: panel (a) lists estimates of BMI model in equation (5), restricted to effects of quitting smoking (e.g., j = 1); panel (b)
in a multi-treatment framework, shows effects of reduction of number of cigarettes by more than 50%, in addition to quitters
(e.g., j = 2). CGALL, CGNS and CG08: control groups described in subsection 3.2. Standard errors in brackets; significant
levels as follows notation: p-value *** ≤ 0.01, ** ≤ 0.05, * ≤ 0.1.
the fitted values of our baseline specification which uses CGS. Much of the BMI variabil-
ity remains unexplained, even after controlling for observable individual characteristics,
and it therefore seems reasonable to assume that individuals with different BMI levels,
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conditional on observable characteristics, respond differently to changes in smoking.
Figure 2 also shows how the quantiles of unconditional and conditional BMI distribu-
tions are different: for example, although a large share of overweight and obese individuals
are located above the upper percentiles of both distributions, we cannot directly interpret
quantile parameters (i.e., βθ1) as the causal effect of quitting smoking on overweight and
obesity but rather as the treatment effect across unobservable individual characteristics.
As done by Kowalski (2009), in order to give an interpretation of quantile regression coef-
ficients we must make assumptions about the nature and dimension of the unobservable
component in our model. Here, we assume that the main source of unobserved hetero-
geneity is given by individuals’ attitude toward risk. We assume that more risk-prone
individuals will gain more weight, because they will not care about the possible adverse
consequences of quitting on their weight.
Figure 2: Scatter plot of BMI unconditional versus BMI conditional distribution values
Panel a) of Table 4 lists the QTEs of quitting smoking on BMI. The estimated QTEs
highlight a significant and increasing effect across the conditional BMI distribution and
vary from a non-significant effect at the 10-th percentile to 0.44 (s.e.=0.178) at the 25-
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th, 0.74 (s.e. = 0.199) at the 50-th, 0.70 (s.e.=0.233) at the 75-th and 0.81 (s.e. =
0.261) at the 90-th percentile of the conditional BMI distribution. If we interpret these
coefficients as the effect of quitting smoking across the distribution of the unobserved
BMI heterogeneity represented by risk propensity, we can conclude that individuals with
lower propensity toward risk tend to increase their BMI less after quitting, because they
are more careful about their weight, whereas more risk-prone individuals will probably
put on more weight - for example, by substituting smoking with more calorie-rich food
or not increasing physical activity. Panel b) of Table 4 lists the estimates from the multi-
treatment model. Irrespective of the quantile analysed we find that, even in this case,
BMI variations are entirely determined by quitting smoking, with very similar coefficients
with respect to the single treatment model.
4.3 Heterogeneous effects across BMI clinical thresholds
One of the objectives of our paper is to estimate the weight gained by obese people after
quitting smoking. We do this, by interacting individuals belonging to a BMI class in 2004
of underweight, normal-weight, overweight and obese with treatments. That is, we can
test whether quitting or reducing smoking have heterogeneous effects on BMI variations in
individuals with different initial conditions in terms of BMI. For the sake of simplicity we
show here only estimates of the effect of quitting smoking, since even in this specification
the effect of reductions is never significant7.
Table 5 lists OLS estimates, in which smokers are assumed to be the control group
(CGS). For the reference category (normal-weight individuals, h = 2), we estimate an
effect of quitting smoking on BMI of 0.31 (s.e. = 0.122) and this coefficient is found
to increase for individuals who belong to higher BMI clinical categories. For overweight
individuals (h = 3), quitting smoking produces an extra BMI increase, with respect to
the effect for the reference category, of 0.48 points (s.e. = 0.214), so that the total BMI
increase for these individuals is 0.79. When we interact the treatment with the obese
category, we also find a positive and significant coefficient of 0.75 (s.e. = 0.384), implying
a total BMI variation of 1.06 points. Lastly, underweight people present a non-significant
coefficient, meaning that their BMI variation after quitting is not statistically different
from that of normal-weight people.
7These estimates are available from the authors upon request.
18
Table 4: Causal effect of quitting smoking on BMI, quantile estimates with CGS
a Treatment: quitting smoking
Variables Q10 Q25 Q50 Q75 Q90
η1 0.05 0.04 0.04 0.04 0.03
(0.080) (0.098) (0.127) (0.110) (0.105)
β1 0.11 0.44** 0.74*** 0.70*** 0.81***
(0.161) (0.178) (0.199) (0.233) (0.261)
δ -0.06 0.14 0.17 0.33*** 0.89***
(0.127) (0.107) (0.122) (0.111) (0.157)
Constant 20.03*** 21.01*** 22.41*** 23.77*** 24.27***
(0.335) (0.224) (0.286) (0.251) (0.245)
Observations 5,796 5,796 5,796 5,796 5,796
R-squared
Adj. R-squared . . . . .
b Multi-treatment: quitting or reducing smoking
η1 0.05 0.05 0.04 0.04 0.03
(0.099) (0.099) (0.121) (0.094) (0.103)
η2 0.08 0.07 0.06 0.09 0.06
(0.093) (0.099) (0.081) (0.079) (0.062)
β1 0.16 0.44*** 0.77*** 0.74** 0.77**
(0.221) (0.154) (0.164) (0.343) (0.323)
β2 0.11 0.06 0.09 0.11 0.01
(0.180) (0.154) (0.070) (0.143) (0.204)
δ -0.07 0.11 0.14 0.30** 0.91***
(0.171) (0.111) (0.131) (0.137) (0.183)
Constant 20.03*** 21.02*** 22.35*** 23.73*** 24.25***
(0.226) (0.171) (0.258) (0.157) (0.176)
Observations 5,796 5,796 5,796 5,796 5,796
R-squared
Adj. R-squared . . . . .
Notes: panel (a) lists estimates of BMI model in equation (8), restricted to effects of quitting smoking (e.g., j = 1); panel (b)
in a multi-treatment framework, shows effects of reduction of number of cigarettes by more than 50%, in addition to quitters
(e.g., j = 2). Standard errors in brackets; significant levels as follows notation: p-value *** ≤ 0.01, ** ≤ 0.05, * ≤ 0.1.
If we look at the δ coefficients, we find a positive and significant variation for normal-
weight people of 0.36 (s.e. = 0.065). Overweight and obese individuals present lower
trends with respect to the reference category, respectively of -0.20 (s.e. = 0.079) and
-0.71 (s.e. = 0.14). In order to calculate the trends for the two categories, we must
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add to the reference category’s parameter the effects estimated through the interaction
terms. That is, the BMI of overweight and obese individuals varies by 0.16 and -0.35
points respectively between 2004 and 2006, consistently with the results from descriptive
statistics shown in Table 2.
Table 5 also lists the estimated parameters from other control groups. We find that
the ATEs obtained when we use CGNS and CGALL as alternative control groups are
lower, but not very distant from those obtained from our baseline model. Lastly, we also
show the estimates using CG08 as control group. Although the ATE is in line with our
expectations in terms of magnitude, we find that is not statistically different from zero.
However, the small size of the obese subsample when CG08 is used as control group does
not allow us to make accurate inferences8.
4.4 IV estimates
We now present a sensitivity analysis of our estimates to check whether the proposed
approach is successful in producing robust results. In the previous sections, we defined a
set of control groups in order to verify our baseline estimates with respect to the possible
bias induced by endogeneity. Alternatively we can use an IV strategy, which consists of
finding one or more exogenous instruments (Z(i)) which must satisfy two properties: they
must be strong predictors of the endogenous regressor - in our case, quitting smoking - and
they must not be correlated with the unobservable component of BMI. In other words, we
need to identify an exogenous variation in smoking behaviour induced by the instruments,
which is not correlated with the unobservable characteristics of BMI and smoking.
We use as instrument the percentage of smokers in the same socio-economic group of
respondents which is a measure of the effect of social interactions on smoking habits. The
underlying idea is that the utility that one smoker receives from consuming a cigarette
is increased by that of other individuals with the same habit and similar socio-economic
characteristics. Specifically, we calculate the percentage of smokers in each region accord-
ing to age, income, education, occupation and marital status. When constructing this
indicator, we exclude from calculation the respondents cigarette smoking. This instru-
ment is assumed to affect the decision to quit smoking negatively and to be uncorrelated
with changes in BMI.
8With CG08 as control group, there are 180 obese individuals in treatment and control groups.
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Table 5: Causal effect of quitting smoking on BMI, by clinical classes and control group
a Treatment model: quitting smoking
Variables CGS CGNS CGALL CG08
η1 -0.09 -0.27*** -0.21** -0.04
(0.107) (0.101) (0.099) (0.149)
η1,1 0.03 -0.10 -0.02 -0.21
(0.241) (0.233) (0.230) (0.299)
η1,3 -0.20 -0.04 -0.09 0.15
(0.163) (0.154) (0.152) (0.220)
η1,4 -0.43 -0.04 -0.13 0.36
(0.387) (0.363) (0.361) (0.500)
β1 0.31** 0.26** 0.27** 0.32*
(0.122) (0.115) (0.115) (0.182)
β1,1 0.47 0.41 0.45 0.32
(0.470) (0.466) (0.463) (0.514)
β1,3 0.48** 0.47** 0.47** 0.65**
(0.214) (0.202) (0.201) (0.310)
β1,4 0.75* 0.63* 0.65* 0.53
(0.384) (0.360) (0.359) (0.590)
δ 0.36*** 0.37*** 0.37*** 0.36**
(0.065) (0.034) (0.030) (0.173)
δ1 -0.07 0.02 -0.01 0.04
(0.098) (0.074) (0.058) (0.232)
δ3 -0.20*** -0.17*** -0.18*** -0.37
(0.079) (0.038) (0.034) (0.233)
δ4 -0.71*** -0.60*** -0.62*** -0.49
(0.140) (0.061) (0.056) (0.459)
Constant 22.25*** 22.70*** 22.52*** 22.23***
(0.230) (0.178) (0.143) (0.608)
Observations 5,796 17,868 22,778 1,656
R-squared 0.80 0.80 0.80 0.78
Adj. R-squared 0.80 0.80 0.80 0.78
Notes: panel (a) lists estimates of BMI model in equation (11), restricted to effects of quitting smoking (e.g., j = 1); panel
(b) in a multi-treatment framework, shows, effects of reduction of number of cigarettes by more than 50%, in addition to
quitters (e.g., j = 2). h = 1, 2, 3, 4 represents BMI clinical classes of underweight, normal-weight, overweight and obesity.
Normal-weight is the reference modality. Standard errors in brackets; significant levels as follows notation: p-value *** ≤
0.01, ** ≤ 0.05, * ≤ 0.1.
In order to perform IV regression, we estimated the single treatment model presented in
equation (5) as its analogous individual first-difference model. Table 6 lists the estimated
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coefficients. We find a significant effect for quitters of 0.71 (s.e. = 0.148) and note that
this value is not much higher than that obtained by OLS in the baseline model (i.e.,
0.59). In the obese subsample, we find that the IV estimate is 1.34 (s.e = 0.614) and
is again slightly larger in magnitude than in the OLS estimates (i.e., 1.06, see Table
5). Although these results show that endogeneity biases our baseline estimates (CGS)
downwards, together with those which use CGNS and CGALL, the difference with respect
to the estimates given by the IV approach are not large in terms of weight. If we consider
a representative individual at the sample average, the estimated weight gain with IV
parameters is 2.05 kg, whereas for a representative obese individual is 3.87 kg, which are
not distant from the corresponding OLS estimates of 1.5 kg and 3.1 kg, respectively.
Table 6: Causal effect of quitting smoking on BMI: IV estimates, with CGS
Variables Full sample Obese
η1 - -
β1 0.71*** 1.34**
(0.148) (0.614)
δ 0.28*** -0.40*
(0.060) (0.224)
Observations 2,898 379
R-squared 0.03 0.04
Adj. R-squared 0.03 0.01
Notes: Standard errors in brackets. Significant levels as follows: p-value *** ≤ 0.01, ** ≤
0.05, * ≤ 0.1.
5 Social costs and benefits
Our estimates identify the robust negative causal effect of smoking on body weight, which
is larger in magnitude for overweight and obese people. This result is of crucial importance
in the health economic literature, since policy-makers are interested in understanding
whether the benefits from savings deriving from reduced smoking are larger or smaller
than the extra costs generated by increased obesity.
Panel a) of Table 7 shows the NHS costs associated with smoking in 2006, which
were estimated by Allender et al. (2009) to be £5,170 million for the UK. As 22% of the
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UK population (60,587,600 in 2006) were smokers, we can calculate the per capita cost of
smoking of £388. In addition, using the estimated total direct cost attributable to obesity
of £3,532 million (McCormick & Stone 2007) and considering that the obese represented
the 24% of the UK total population in 2006, we obtain a per-capita cost of obesity of
£243.
Panel b) of Table 7 lists the benefits of reduced smoking and the costs of the resulting
increased obesity. From the BHPS, we can estimate that obese smokers decreased by
2.78% between 2004 and 2006, so that this percentage can be used to calculate that
the direct social benefits, in terms of NHS cost reductions attributable to smoking, were
£156.81 million. This figure is obtained by multiplying the number of obese individuals
who quit smoking (i.e., 406,000, 2.8% of 14.54 million obese individuals in 2004) by the
per capita cost of smoking (£388).
We also calculated the estimated social costs associated with increased obesity, at-
tributable to quitting smoking. They arise from two different sources: 1) the extra costs
of also having to treat those individuals who were overweight in 2004 and who, because of
smoking-related weight increases, became obese in 2006; 2) the ‘’lost benefits” for having
to treat those individuals who were already obese in 2004 and who, because they stopped
smoking, did not become overweight in 2006. From our empirical model, the BMI in 2006
is a linear function of two components, δ+β1, all other characteristics remaining constant.
Estimates of equation (11) listed in Table 5 show the effect of quitting smoking on BMI
of overweight individuals in 2004, which is β1 + β1,3 = 0.79. In order to exclude those
individuals who would have become obese because of other factors, we must add to this
value the estimated BMI growth trend, represented by δ + δ3, of 0.16. In other words,
our model predicts that overweight smokers who quit smoking and had a BMI greater
than 29.05 (but lower than 29.85) in 2004, will become obese in 2006 (BMI > 30 in 2006)
because of quitting smoking. This quota of individuals represents an extra cost which the
NHS would not have sustained in a scenario in which nobody quits.
In addition, again looking at Table 5, our estimates indicate a negative trend for obese
people (δ + δ4 = −0.35), implying that those who had a BMI higher than 30, but lower
than 30.35 in 2004, would become overweight in 2006 and do not represent a cost (at
least in terms of obesity) for the NHS. But, if we look at the obese individuals who also
quit smoking in 2006, the positive effect associated with quitting, β1+β1,4 = 1.06, clearly
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overcompensates the natural decreasing trend of BMI, and keeps a significant number of
individuals trapped in obesity. These people represent a lost benefit for the NHS in terms
of savings due to reduced obesity. All the other individuals classified as obese in 2006
would have been obese in any case, and consequently are not considered as a burden for
the NHS.
Again panel b) of Table 7, shows the estimates of the costs described previously. The
percentage of individuals with BMI > 29.05 and < 29.85 in 2004, estimated by the BHPS,
is 4.43% of the total population (i.e., 2.68 million people). If we assume that 2.78% of the
UK population (i.e., a sample of 74,619) quit smoking in 2006, we obtain an additional cost
for the NHS of £18.13 million (74,619 × £243). Moreover, the percentage of individuals
with BMI > 30 and < 30.35 in 2004 was 1.71% (i.e., 1,036 million people). Also in this
case, we assume that the 2.78% of these individuals quit smoking (i.e., 28,803 people)
and estimate a lost benefit of £6.99 million (20.803 × £243). Lastly, the net benefit of
£131.69 million is estimated by subtracting these costs from the total benefit.
Table 7: Social costs and benefits of quitting smoking
Panel a
UK Population 60.59 Millions
Percentage of smokers 0.22 %
Cost of smoking 5170.5 Millions of £
Percentage of overweight people 0.38 %
Percentage of obese people 0.24 %
Cost of obesity 3532 Millions of £
Per capita cost of smoking 387.91 £
Per capita cost of obesity 242.9 £
Social benefits of quitting smoking 156.81 Millions of £
Panel b
(δ + δ3) + (β1 + β1,3), CGS 0.79+0.16
(δ + δ4) + (β1 + β1,4), CGS 1.06-0.35
Obese quitters between 2004/2006 (estimated by BHPS) 0.0278 %
Percentage of overweight individuals with BMI > 29.05 and < 29.85 4.43 %
Percentage of obese individuals with BMI < 30.35 and > 30 1.71 %
Social costs of increased obesity: overweight with BMI >29.05 and < 29.85 18.13 Millions of £
Social costs of increased obesity: obese with BMI < 30.35 6.99 Millions of £
Net social benefits of quitting smoking 131.69 Millions of £
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6 Conclusions
Much has been written about the determinants of weight gains in modern society, with
particular emphasis on the health risks of obese people. Among these, abandoning the
habit of smoking appears to play a significant role in view of the close correlation between
the number of those who stop smoking and their body weight. This paper extends the
current literature to examine whether a trade-off exists between smoking and weight gains
using longitudinal data from the UK. Identification of causal coefficients in terms of BMI
changes was carried out in a framework which included the potential effect of people who
reduced smoking as well as quitting. In order to consider the heterogeneous response of
BMI to changes in cigarette consumption, we also used quantile regression to obtain QTE.
We reject the hypothesis that reduced smoking can affect weight changes at each
estimated point of the BMI distribution, as an increasing effect was revealed in obese
people who quit. Robustness analysis confirmed these findings when several control groups
were used. We also show the slightly greater impact of quitters on weight changes when
the model parameters were estimated with the IV estimator. The latter result becomes
evident around the threshold of obesity, indicating that most smokers who quit were
concerned about their health, although this may imply a negative externality in terms of
weight.
Following on from these results, we also present cost-benefit calculations, in which the
benefits of quitting in the UK are greater than the cost of overweight. These estimates
should be carefully and cautiously interpreted. First, we observe the heterogeneous be-
haviour of quitting around the obese cut-off point. In our cost-benefit analysis, lack of
information of various points of the BMI distribution only allows us to use, for example,
the mean of the obese group, with a plausible bias as regard the exact cost of giving up
smoking. Secondly, we assess the effect of quitting on BMI over a period of two years,
which is perhaps not long enough for complete evaluation of the effects, as pointed out
in the meta-analyses of Klesges et al. (1989) or by Courtemanche (2009). However, even
after these criticisms have been taken into account, the estimate of the net social benefit,
which emerges from our calculations seems large, indicating that continuing to emphasise
the health risks of smoking should be maintained and that current smokers should be
encouraged to abandon the habit, diminishing the social cost of correlated diseases.
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APPENDIX A
Table A: Descriptive statistics of covariates
Respondents who quit smoking Respondents who continued smoking
between 2004 and 2006 (TGQ) between 2004 and 2006 (CGS)
2004 2006 2004 2006
Variable Mean Std. Dev. Mean Std. Dev. Mean Std. Dev. Mean Std. Dev.
Male 0.49 0.5 0.49 0.5 0.46 0.5 0.46 0.5
Female 0.51 0.5 0.51 0.5 0.54 0.5 0.54 0.5
Goes for a drink at least once a week 0.37 0.48 0.29 0.46 0.34 0.47 0.33 0.47
Goes for a drink at least once a month 0.23 0.42 0.28 0.45 0.24 0.43 0.22 0.41
Goes for a drink several times a year 0.16 0.37 0.18 0.38 0.17 0.38 0.18 0.39
Goes for a drink once a year or less 0.05 0.22 0.04 0.2 0.07 0.25 0.06 0.24
Goes for a drink never/almost never 0.19 0.39 0.21 0.41 0.18 0.38 0.21 0.41
Health status is excellent 0.22 0.41 0.21 0.41 0.17 0.38 0.19 0.39
Health status is good 0.44 0.5 0.43 0.5 0.45 0.5 0.44 0.5
Health status is fair 0.23 0.42 0.23 0.42 0.25 0.43 0.24 0.43
Health status is poor 0.09 0.29 0.11 0.31 0.1 0.3 0.1 0.3
Health status is very poor 0.02 0.13 0.02 0.15 0.03 0.17 0.03 0.18
Non-long-term sick 0.94 0.24 0.95 0.22 0.91 0.28 0.91 0.28
Long-term sick 0.06 0.24 0.05 0.22 0.09 0.28 0.09 0.28
Hours worked weekly (including overtime) 39.59 11.43 38.17 12.36 37.91 13.61 37.64 12.99
Strenuous job 0.24 0.43 0.24 0.43 0.33 0.47 0.31 0.46
Non-strenuous job 0.76 0.43 0.76 0.43 0.67 0.47 0.69 0.46
Working mother 0.41 0.49 0.37 0.48 0.35 0.48 0.34 0.47
Non-working mother 0.59 0.49 0.63 0.48 0.65 0.48 0.66 0.47
Ethnic group: white 0.99 0.11 0.99 0.11 0.99 0.08 0.99 0.08
Ethnic group: other 0.01 0.11 0.01 0.11 0.01 0.08 0.01 0.08
Age 18-29 0.26 0.44 0.21 0.41 0.22 0.42 0.18 0.39
Age 30-39 0.25 0.43 0.25 0.43 0.24 0.42 0.23 0.42
Age 40-49 0.15 0.35 0.18 0.38 0.21 0.41 0.23 0.42
Age 50-59 0.12 0.33 0.12 0.33 0.18 0.38 0.18 0.39
Age 60+ 0.22 0.41 0.24 0.43 0.15 0.36 0.18 0.39
1st quintile of net income 0.23 0.42 0.2 0.4 0.28 0.45 0.26 0.44
2nd quintile of net income 0.18 0.39 0.21 0.41 0.23 0.42 0.23 0.42
3rd quintile of net income 0.23 0.42 0.21 0.41 0.21 0.41 0.2 0.4
4th quintile of net income 0.2 0.4 0.2 0.4 0.16 0.36 0.17 0.38
5th quintile of net income 0.15 0.36 0.19 0.39 0.12 0.32 0.14 0.35
Couple 0.18 0.39 0.18 0.39 0.2 0.4 0.19 0.39
Married 0.46 0.5 0.5 0.5 0.43 0.5 0.44 0.5
Divorced 0.06 0.24 0.08 0.27 0.09 0.29 0.1 0.3
Separated 0.03 0.16 0.02 0.13 0.03 0.18 0.03 0.17
Widowed 0.05 0.21 0.05 0.22 0.05 0.21 0.05 0.23
Never Married 0.22 0.42 0.17 0.38 0.2 0.4 0.19 0.39
Degree 0.13 0.34 0.14 0.35 0.06 0.24 0.07 0.25
Diploma 0.26 0.44 0.29 0.45 0.25 0.43 0.28 0.45
A-level 0.11 0.31 0.1 0.3 0.12 0.32 0.11 0.31
O-level 0.17 0.38 0.17 0.37 0.19 0.39 0.18 0.38
Low educated 0.1 0.3 0.09 0.29 0.1 0.29 0.09 0.28
No qualification 0.2 0.4 0.19 0.39 0.26 0.44 0.25 0.43
Still at school 0 0 0 0 0.01 0.08 0.01 0.07
England 0.52 0.5 0.54 0.5 0.43 0.49 0.44 0.5
Wales 0.14 0.35 0.14 0.35 0.17 0.38 0.17 0.38
Scotland 0.17 0.37 0.16 0.37 0.19 0.39 0.19 0.39
Northern Ireland 0.15 0.36 0.15 0.36 0.19 0.4 0.19 0.4
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